The Problem of Chemically Reactive Metabolites

References

• Gillette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity: I. Correlation of changes in covalent binding of reactive metabolites with changes in the incidence and severity of toxicity. Biochem. Pharmacol. 1974; 23: 2785–2794
   PubMed Web of Science ®Google Scholar
• Gillette J. R. A perspective on the role of chemically reactive metabolite: II. Alterations in the kinetics of covalent binding. Biochem. Pharmacol. 1974; 23: 2927–2938
   PubMed Web of Science ®Google Scholar
• Gillette J. R. Toxicological implications of drug metabolism, The Induction of Drug Metabolism: Symposia Medical Hoechst 14 Stuttgart, R. W. E. stab rook, E. Lindenlaub. Schattauer Verlag, New York 1978; 309–341
   Google Scholar
• Gillette J. R. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds. DrugMetab. Rev. 1979; 10: 59–87
   PubMed Web of Science ®Google Scholar
• Gillette J. R. Pharmacokinetic factors governing the steady-state concentrations of foreign chemicals and their metabolites. Ciba Foundation Symposium, D. Evered, G. Lawrenson. Excerpta Medica, Oxford, New York 1980; 191–217, new series vol. 76
   Google Scholar
• Enzyme-Activated Irreversible Inhibitors, N. Seiler, M. J. Jung, J. Koch-Weser. Elsevier/North Holland Biomedical Press. 1978
   Google Scholar
• Menard R. H., Guenthner T. M., Kon H., Gillette J. R. Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. J. Biol. Chem. 1979; 25: 1726–1733
   Google Scholar
• Menard R. H., Guenthner T. M., Taburet A. M., Kon H., Pohl L. R., Gillette J. R., Gelboin H. V., Trager W. F. Specificity of the in vitro destruction of adrenal and hepatic microsomal steroid hydroxylase by thiosteroids. Mol. Pharmacol. 1979; 16: 997–1010
   PubMed Web of Science ®Google Scholar
• Chambon P. Split genes, Sci. Am. 1981; 244(5)60–71
   Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis: I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 1973; 187: 185–187
   PubMed Web of Science ®Google Scholar
• Potter W. Z., Thorgeirsson S. S., Jollow D. J., Mitchell J. R. Acetaminophen-induced hepatic necrosis: V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology 1974; 12: 129–143
   PubMed Web of Science ®Google Scholar
• Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis: III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 1973; 187: 203–210
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Thorgeirsson S. S., Potter W. Z., Hashimoto M., Mitchell J. R. Acetaminophen-induced hepatic necrosis: VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology 1974; 12: 251–271
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Potter W. Z., Hinson J. H., Jollow D. J. Hepatic necrosis caused by furosemide, a furan-containing diuretic. Nature (London) 1974; 251: 508–511
   PubMed Web of Science ®Google Scholar
• Spitznagle L. A., Wirth P. J., Boobis S. W., Thorgeirsson S. S., Nelson W. L. The role of biliary excretion in the hepatotoxicity of furosemide in the mouse. Toxicol. Appl. Pharmacol. 1977; 39: 283–294
   PubMed Web of Science ®Google Scholar
• Boyd M. R. Evidence for the Clara cell as a site of cytochrome P-450 dependent mixed function oxidase activity in lung. Nature (London) 1977; 269: 713–715
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Burka L. T. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J. Pharmacol. Exp. Ther. 1978; 207: 687–697
   PubMed Web of Science ®Google Scholar
• Reid W. D., Ilett K. F., Glick J. M., Krishna G. Metabolism and binding of aromatic hydrocarbons in the lung. Am. Rev. Resp. Dis. 1973; 107: 539–551
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Krishna G. Deuterium isotope effect in bioactivation and hepatotoxicity of chloroform. Life Sci. 1978; 23: 1067–1072
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Martin J. L., Taburet A. M., George J. W. Oxidative bioactivation of haloforms into hepato-toxins, Microsomes, Drug Oxidations and Chemical Carcinogenesis, M. J. Coon, A. H. Conney, R. W. Estabrook, J. R. Gillette, P. J. O'Brien. Academic Press, New York 1980; vol. 2: 881–884
   Google Scholar
• Zampaglione N., Jollow D. J., Mitchell J. R., Stripp B., Hamrick M., Gillette J. R. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J. Pharmacol. Exp. Ther. 1973; 187: 218–227
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Forte A. J., Vaishnav Y., Mitchell J. R., Gillette J. R., Hinson J. A. The formation of aryl-ating and alkylating metabolites of phenacetin in hamsters and hamster liver microsomes. Mol. Pharmacol. 1981; 19: 140–145
   PubMed Web of Science ®Google Scholar
• Gillette J. R., Nelson S. D., Mulder G. J., Jollow D. J., Mitchell J. R., Pohl L. R., Hinson J. A. Formation of chemically reactive metabolites of phenacetin and acetaminophen. Biological Reactive Intermediates, R. Synder, D. Parke, J. Kocsis, D. Jollow, G. Gibson, S. Witmer. Plenum Press, New York 1982; 931–950, part B
   Google Scholar
• Axelrod J. The enzymatic cleavage of aromatic ethers. Biochem. J. 1956; 63: 634–639
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Pohl L. R., Monks T. J., Gillette J. R., Guengerich F. P. 3-Hydroxyacetaminophen: A microsomal metabolite of acetaminophen: Evidence against an epoxide as the reactive metabolite of acetaminophen. Drug Metab. Dispos. 1980; 8: 289–294
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Mitchell J. R. N-Hydroxylation of phenacetin by hamster liver microsomes. Drug Metab. Dispos. 1976; 4: 430–435
   PubMed Web of Science ®Google Scholar
• Mulder G. J., Hinson J. A., Gillette J. R. Generation of reactive metabolite of N-hydroxyphenacetin by glucuronidation and sulfation. Biochem. Pharmacol. 1977; 26: 189–196
   PubMed Web of Science ®Google Scholar
• Mulder G. J., Hinson J. A., Gillette J. R. Conversion of the N-O-glucuronide and N-O-sulfate conjugates of N-hydroxyphenacetin to reactive intermediates. Biochem. Pharmacol. 1978; 27: 1641–1650
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Andrews L. S., Gillette J. R. Kinetic evidence for multiple chemically reactive intermediates in the breakdown of phenacetin N-O-glucuronide. Pharmacology 1979; 19: 237–248
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Pohl L. R., Gillette J. R. N-hydroxy-acetaminophen: A microsomal metabolite of N-hydroxy phenacetin but apparently not of acetaminophen. Life Sci. 1979; 24: 2133–2138
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Nelson S. D., Gillette J. R. Metabolism of ‘p-18O’-phenacetin: The mechanism of activation of phenacetin to reactive metabolites in hamsters. Mol. Pharmacol. 1979; 15: 419–427
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Jensen N. M., Levitt R. C., Felton J. R. Toxic chemical depression of the bone marrow and possible aplastic anemia explanable on a genetic basis. Clin. Toxicol. 1980; 16: 99–122
   PubMed Web of Science ®Google Scholar
• Dietz F. K., Stott W. T., Ramsey J. C. Nonlinear pharmacokinetics and their impact on toxicology: Illustrated with dioxane. Drug Metab. Rev. 1982; 13(6)963–981
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Roberts S., Price V., Longacre S., Smith C. Pharmacokinetic considerations in toxicity testing. Drug Metab. Rev. 1982; 13(6)983–1007
   PubMed Web of Science ®Google Scholar
• Levy G., Galinsky R. E., Lin J. H. Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion. Drug Metab. Rev. 1982; 13(6)1009–1019
   PubMed Web of Science ®Google Scholar
• Webb J. L. Enzyme and Metabolic Inhibitors. Academic Press, New York, London 1963; vol. 1: 42
   Google Scholar
• Mitchell J. R., Zimmerman H. J., Ishak K. G., Thorgeirsson V. P., Timbrell J. A., Snodgrass W. R., Nelson S. D. Isoniazid liver injury: Clinical spectrum, pathology and probable pathogenesis. Ann. Intern. Med. 1976; 84: 181–192
   PubMed Web of Science ®Google Scholar